CEO of BioMarin Pharmaceutical Inc. (BMRN, Financial) Jean Jacques Bienaime sells 1,000 shares of BMRN on 12/13/2010 at an average price of $27.43 a share.
Biomarin Pharmaceutical Inc. has a market cap of $2.79 billion; its shares were traded at around $27.26 with a P/E ratio of 1363 and P/S ratio of 8.61.
BMRN is in the portfolios of Richard Aster Jr of Meridian Fund, Columbia Wanger of Columbia Wanger Asset Management, PRIMECAP Management, Stanley Druckenmiller of Duquesne Capital Management, LLC, RS Investment Management, Pioneer Investments, Bruce Kovner of Caxton Associates, Steven Cohen of SAC Capital Advisors, Chuck Royce of Royce& Associates.
Biomarin Pharmaceutical Inc. has a market cap of $2.79 billion; its shares were traded at around $27.26 with a P/E ratio of 1363 and P/S ratio of 8.61.
BMRN is in the portfolios of Richard Aster Jr of Meridian Fund, Columbia Wanger of Columbia Wanger Asset Management, PRIMECAP Management, Stanley Druckenmiller of Duquesne Capital Management, LLC, RS Investment Management, Pioneer Investments, Bruce Kovner of Caxton Associates, Steven Cohen of SAC Capital Advisors, Chuck Royce of Royce& Associates.
CEO Recent Trades:
- Sell: CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 12/06/2010 at the average price of 27.17. Jean Jacques Bienaime owns at least 93,567 shares after this. The price of the stock has increased by 0.33% since.
- Sell: CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 12/06/2010 at the average price of 27.17. Jean Jacques Bienaime owns at least 93,567 shares after this. The price of the stock has increased by 0.33% since.
- Sell: CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 11/23/2010 at the average price of 27.02. Jean Jacques Bienaime owns at least 93,567 shares after this. The price of the stock has increased by 0.89% since.
- Sell: CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 11/18/2010 at the average price of 25.99. Jean Jacques Bienaime owns at least 93,567 shares after this. The price of the stock has increased by 4.89% since.
- Sell: CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 11/08/2010 at the average price of 25.78. Jean Jacques Bienaime owns at least 93,567 shares after this. The price of the stock has increased by 5.74% since.
CFO Recent Trades:
- Sell: SVP, CFO Jeffrey H Cooper sold 11,250 shares of BMRN stock on 11/24/2010 at the average price of 27.5. Jeffrey H Cooper owns at least 26,810 shares after this. The price of the stock has decreased by 0.87% since.
- Sell: SVP, CFO Jeffrey H Cooper sold 28,750 shares of BMRN stock on 10/29/2010 at the average price of 25.32. Jeffrey H Cooper owns at least 26,486 shares after this. The price of the stock has increased by 7.66% since.
- Sell: SVP, CFO Jeffrey H Cooper sold 15,209 shares of BMRN stock on 10/25/2010 at the average price of 24. Jeffrey H Cooper owns at least 26,486 shares after this. The price of the stock has increased by 13.58% since.
- Sell: SVP, CFO Jeffrey H Cooper sold 6,000 shares of BMRN stock on 09/13/2010 at the average price of 22.85. Jeffrey H Cooper owns at least 26,486 shares after this. The price of the stock has increased by 19.3% since.
Directors and Officers Recent Trades:
- Sell: EVP, Chief Medical Officer Henry J Fuchs sold 834 shares of BMRN stock on 12/01/2010 at the average price of 27.08. Henry J Fuchs owns at least 31,000 shares after this. The price of the stock has increased by 0.66% since.
- Sell: SVP, General Counsel George Eric Davis sold 5,000 shares of BMRN stock on 11/24/2010 at the average price of 27.5. George Eric Davis owns at least 27,901 shares after this. The price of the stock has decreased by 0.87% since.
- Sell: VP, Human Resources Mark Wood sold 2,479 shares of BMRN stock on 11/22/2010 at the average price of 26.6. Mark Wood owns at least 14,243 shares after this. The price of the stock has increased by 2.48% since.
- Sell: EVP, Chief Business Officer Steve Aselage sold 39,875 shares of BMRN stock on 11/18/2010 at the average price of 25.84. Steve Aselage owns at least 29,881 shares after this. The price of the stock has increased by 5.5% since.
- Sell: SVP, General Counsel George Eric Davis sold 10,371 shares of BMRN stock on 11/04/2010 at the average price of 25.83. George Eric Davis owns at least 27,901 shares after this. The price of the stock has increased by 5.54% since.
